Literature DB >> 15185391

FK506 enhances regeneration of axons across long peripheral nerve gaps repaired with collagen guides seeded with allogeneic Schwann cells.

Esther Udina1, Francisco J Rodríguez, Enrique Verdú, Mónica Espejo, Bruce G Gold, Xavier Navarro.   

Abstract

We assessed the effects of FK506 administration on regeneration after a 6-mm gap repair with a collagen guide seeded with allogeneic Schwann cells (SCs) in the mouse sciatic nerve. SCs were isolated from predegenerated adult sciatic nerves and expanded in culture using a defined medium, before being seeded in the collagen guide embedded in Matrigel. Functional reinnervation was evaluated by noninvasive methods to determine recovery of motor, sensory, and autonomic functions in the hindpaw over 4 months postoperation. Histological analysis of the regenerated nerves was performed at the end of the study. Using simple collagen guides for tubulization repair, treatment with an immunosuppressant dose of FK506 (5 mg/kg/day) resulted in significant improvement of the onset and the degree of reinnervation. While the introduction of allogeneic SCs did not improve regeneration versus a collagen guide filled only with Matrigel, treatment with FK506 allowed for successful regeneration in all the mice and for significant improvement in the levels of functional recovery. Compared with the untreated group, there was greater survival of transplanted pre-labeled SCs in the FK506-treated animals. Morphologically, the best nerve regeneration (in terms of nerve caliber and numbers of myelinated axons) was obtained with SC-seeded guides from FK506-treated animals. Thus, FK506 should be considered as adjunct therapy for various types of tubulization repair. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185391     DOI: 10.1002/glia.20025

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  16 in total

1.  Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes.

Authors:  Abel Torres-Espín; Elena Redondo-Castro; Joaquim Hernandez; Xavier Navarro
Journal:  J Neurotrauma       Date:  2015-01-22       Impact factor: 5.269

2.  Functional, Histopathological and Immunohistichemical Assessments of Cyclosporine A on Sciatic Nerve Regeneration Using Allografts: A Rat Sciatic Nerve Model.

Authors:  Amir Amniattalab; Rahim Mohammadi
Journal:  Bull Emerg Trauma       Date:  2017-07

3.  Biofabrication and testing of a fully cellular nerve graft.

Authors:  Christopher M Owens; Francoise Marga; Gabor Forgacs; Cheryl M Heesch
Journal:  Biofabrication       Date:  2013-11-06       Impact factor: 9.954

4.  Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.

Authors:  María Moreno-Igoa; Ana Cristina Calvo; Clara Penas; Raquel Manzano; Sara Oliván; María Jesús Muñoz; Renzo Mancuso; Pilar Zaragoza; José Aguilera; Xavier Navarro; Rosario Osta Pinzolas
Journal:  J Mol Med (Berl)       Date:  2010-03       Impact factor: 4.599

5.  Aligned Protein-Polymer Composite Fibers Enhance Nerve Regeneration: A Potential Tissue-Engineering Platform.

Authors:  Sing Yian Chew; Ruifa Mi; Ahmet Hoke; Kam W Leong
Journal:  Adv Funct Mater       Date:  2007       Impact factor: 18.808

6.  Nerve-specific, xenogeneic extracellular matrix hydrogel promotes recovery following peripheral nerve injury.

Authors:  Travis A Prest; Eric Yeager; Samuel T LoPresti; Emilija Zygelyte; Matthew J Martin; Longying Dong; Alexis Gibson; Oluyinka O Olutoye; Bryan N Brown; Jonathan Cheetham
Journal:  J Biomed Mater Res A       Date:  2017-10-23       Impact factor: 4.396

7.  Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule.

Authors:  Ana C Calvo; María Moreno-Igoa; Renzo Mancuso; Raquel Manzano; Sara Oliván; María J Muñoz; Clara Penas; Pilar Zaragoza; Xavier Navarro; Rosario Osta
Journal:  Orphanet J Rare Dis       Date:  2011-03-21       Impact factor: 4.123

Review 8.  Peripheral nerve repair with cultured schwann cells: getting closer to the clinics.

Authors:  Maria Carolina O Rodrigues; Antonio Antunes Rodrigues; Loren E Glover; Julio Voltarelli; Cesario V Borlongan
Journal:  ScientificWorldJournal       Date:  2012-06-04

Review 9.  Carriers in cell-based therapies for neurological disorders.

Authors:  Francisca S Y Wong; Barbara P Chan; Amy C Y Lo
Journal:  Int J Mol Sci       Date:  2014-06-13       Impact factor: 6.208

10.  Rapamycin promotes Schwann cell migration and nerve growth factor secretion.

Authors:  Fang Liu; Haiwei Zhang; Kaiming Zhang; Xinyu Wang; Shipu Li; Yixia Yin
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.